The Biden Administration Takes Aim At Medical Financing Products

This month, the Biden administration issued a Request for Information (RFI) on “the scope, prevalence, terms, and impacts” of medical credit cards and other high-cost medical financing products. In a post for Health Affair’s Forefront, CHIR’s Maanasa Kona explains the RFI and outlines some of the risks these products pose for patients.